June 15, 2024

Medical Trend

Medical News and Medical Resources

COVID Omicron subvariant “Arcturus” has the first death case!

COVID Omicron subvariant “Arcturus” has the first death case!


COVID Omicron subvariant “Arcturus” has the first death case! Expert: Pay attention to “these symptoms”

The COVID-19 pneumonia Omicron subvariant virus strain XBB.1.16 “Arcturus” has recently wreaked havoc in India again.

In this regard, in order to prevent a large-scale outbreak of the epidemic, the New Delhi authorities, in addition to ordering the resumption of vaccine production, also announced the mandatory wearing of masks.

It is said that there have been related cases of “Arcturus” in 29 countries around the world, and the world’s first death case in Thailand. It is reported that this virus infects faster and is related to eye diseases. Patients are prone to conjunctivitis. Experts call on the public to pay attention.


COVID Omicron subvariant "Arcturus" has the first death case!




Based on the reports of “Thailand Public Television” and the British “Mirror”, Supakit Sirilak, director of the Medical Sciences Department of the Ministry of Public Health of Thailand, reported on the 20th that as of April 17th, Thailand had recorded a total of 27 cases of new coronavirus Cases of pneumonia (COVID-19) mutant strain “Arcturus”, including 1 death.

Supaji pointed out that the deceased was an “elderly foreigner with underlying health problems,” so the cause of death may not necessarily reflect the severity of the mutant strain and may be affected by other factors.


However, Yong Poovorawan, director of the Center for Clinical Virology Research at Chulalongkorn University in Bangkok, warned that Arcturus may have become the mainstream variant in Thailand. The number of patients hospitalized with the virus between April 9 and 15 tripled and a half from the previous week, the report said.


Russia’s health watchdog, Rospotrebnadzor, said on the 18th that Arcturus may be “more contagious, but not highly lethal.”


According to the epidemiological report of the World Health Organization (WHO) on the 13th, there are currently XBB.1.16 related cases in 29 countries around the world, including the United States, the United Kingdom, Singapore, India, Nepal, Australia and other countries. But the vast majority of cases are in India and Nepal.

WHO has also been monitoring it continuously since March 22.


Information about  COVID Omicron subvariant “Arcturus”


The COVID-19 Omicron subvariant “Arcturus” is a real variant of the virus. The World Health Organization (WHO) uses the Greek alphabet to name the primary COVID-19 variants of concern and interest, such as Alpha, Beta, Gamma, Delta, and Omicron. Sub-lineages of these variants can be identified by adding a designation after the Greek letter, such as Omicron subvariant “Arcturus.”

The Arcturus subvariant of the Omicron variant was first identified in South Africa in November 2021. This subvariant has a unique set of mutations compared to other Omicron sub-lineages and may have an impact on the transmissibility and severity of the virus. However, research is still ongoing to understand the characteristics and implications of this subvariant.

It’s worth noting that the naming of subvariants is not standardized, and different countries and research groups may use different naming conventions. Therefore, it’s important to rely on reliable sources of information when trying to stay up to date on COVID-19 variants.




Is there any drug or vaccine against COVID Omicron subvariant “Arcturus?

At the moment, there is no specific drug or vaccine that has been developed specifically for the Omicron subvariant “Arcturus” of the COVID-19 virus. However, the existing COVID-19 vaccines and treatments are still effective against the Omicron variant, including its various sub-lineages, although their efficacy may be reduced compared to their effectiveness against earlier variants of the virus.

The World Health Organization (WHO) recommends that individuals continue to follow preventive measures such as wearing masks, washing hands regularly, and practicing physical distancing, even if they have been fully vaccinated.

Additionally, booster shots are being recommended for individuals who have already received the full course of a COVID-19 vaccine, especially those who are at high risk or who were vaccinated several months ago.


Research is ongoing to develop new treatments and vaccines that may be more effective against the Omicron subvariant and other emerging variants of the virus.

It’s essential to stay updated with the latest developments and recommendations from reliable sources such as the WHO, Centers for Disease Control and Prevention (CDC), and other public health organizations.





COVID Omicron subvariant “Arcturus” has the first death case!

(source:internet, reference only)

Disclaimer of medicaltrend.org

Important Note: The information provided is for informational purposes only and should not be considered as medical advice.